July 30, 2021 - ROSEN LOGO.jpg
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CKPT
May 06, 2024 20:34 ET | The Rosen Law Firm PA
NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) between March...
Close Up Logo HD Blue.jpg
DEADLINE ALERT for IRBT, HRT, and CKPT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
May 06, 2024 12:08 ET | The Law Offices of Frank R. Cruz
LOS ANGELES, May 06, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded...
Close Up Logo HD Blue.jpg
DEADLINE ALERT for HRT and CKPT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
May 01, 2024 12:06 ET | The Law Offices of Frank R. Cruz
LOS ANGELES, May 01, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded...
James (Josh) Wilson Faruqi & Faruqi, LLP
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint
May 01, 2024 09:45 ET | Faruqi & Faruqi LLP
NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Checkpoint Therapeutics, Inc. (“Checkpoint” or...
Close Up Logo HD Blue.jpg
DEADLINE ALERT for HRT, CKPT, and SOND: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
April 25, 2024 12:07 ET | The Law Offices of Frank R. Cruz
LOS ANGELES, April 25, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, LEADING INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CKPT
April 24, 2024 20:23 ET | The Rosen Law Firm PA
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) between March...
James (Josh) Wilson Faruqi & Faruqi, LLP
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint
April 23, 2024 07:30 ET | Faruqi & Faruqi LLP
NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Checkpoint Therapeutics, Inc. (“Checkpoint”...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CKPT
April 21, 2024 12:12 ET | The Rosen Law Firm PA
NEW YORK, April 21, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) between...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CKPT
April 17, 2024 18:22 ET | The Rosen Law Firm PA
NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) between March...
James (Josh) Wilson Faruqi & Faruqi, LLP
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint
April 17, 2024 07:30 ET | Faruqi & Faruqi LLP
NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Checkpoint Therapeutics, Inc. (“Checkpoint”...